Orlynvah, an oral tablet from drug manufacturer Iterum Therapeutics, combining sulopenem etzadroxil and probenecid has been approved for use specifically for treating uncomplicated urinary tract infections (UTIs) in adult women.Original Article
New UTI Drug Gets FDA Approval: Alternative For Patients With Limited Antibacterial Treatment Options
